aTyr raises $10.5 million

aTyr (San Diego, Calif.) raised $10.5 million in a series B round co-led by new investors Alta Partners and Polaris Venture Partners. Imagene, another new investor, and founding investor Cardinal Partners also participated. The company is developing a family of naturally occurring biologics with undisclosed mechanisms of action, including two lead candidates that have shown in vivo efficacy in disease areas including cancer, neurology and vascular, inflammatory, metabolic, and dermatologic disorders. aTyr expects to narrow development down to specific indications within a year and to submit an IND by 2009. ...